Characterization of chronic cough patients participating in a phase 2b clinical trial of gefapixant, a P2X3 receptor antagonist

Conclusions: Large proportions of chronic cough patients in this trial were diagnosed with GERD, asthma, or allergic rhinitis. Despite receiving treatment for these conditions, chronic cough for these subjects had persisted for over a decade.

Source: European Respiratory Journal - November 20, 2019 Category: Respiratory Medicine Authors: McGarvey, L., Smith, J., Birring, S., Morice, A., Sher, M., Wu, W.-C., Muccino, D. Tags: Clinical Problems Source Type: research